Baxter Newsroom
Nov 8, 2024 · We invite you to read the latest news about our initiatives and innovations, and follow us on our corporate social media channels to receive timely updates.
Baxter Announces Strategic Actions to Enhance Operational …
Jan 6, 2023 · Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders.
Baxter Reports First-Quarter 2024 Results
May 2, 2024 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
Baxter - Baxter Reports Third-Quarter 2024 Results
Nov 8, 2024 · On Aug. 13, 2024, Baxter and certain affiliates of global investment firm Carlyle announced a definitive agreement under which Carlyle is to acquire Baxter’s Kidney Care segment, to be known as Vantive, for $3.80 billion. Baxter expects to receive approximately $3.50 billion in cash with net after-tax proceeds currently estimated to be in the ...
Baxter Announces Definitive Agreement to Divest Its Vantive …
Aug 13, 2024 · Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8 billion.
Investors - Events & News - Baxter
Information regarding Baxter’s recent announcements, upcoming & past events, and other useful resources for investors. Annual Reports & Proxy. Baxter's Annual Chairman Letter, Proxy Statement and Form 10-K filings sorted by year. Financial Schedules. Financial schedules and Non-GAAP reconciliations by quarter. SEC Filings
Hurricane Helene Updates | Baxter
Dec 19, 2024 · Baxter is providing periodic updates regarding its progress to restore operations at its North Cove, N.C., site following Hurricane Helene. The Dec. 19 update will be the company’s last post for 2024. Baxter’s next update is expected to be posted in early 2025.
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
Feb 8, 2024 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024.
Baxter Announces Continued Growth of Pharmaceuticals Portfolio …
Dec 11, 2024 · Baxter’s comprehensive pharmaceuticals portfolio contains injectables (including ready-to-use products), inhaled gases and compounded medications, and is designed to expand access to products that simplify medication preparation and support patient safety.
Baxter - Baxter Provides Update on North Cove, N.C., Facility and ...
Sep 29, 2024 · Baxter’s North Cove facility affected by flooding and currently closed for production as the company assesses extent of the impact; Company is working closely with FDA, ASPR, HHS, FEMA, Department of Homeland Security and local and state officials